Bioventus Inc.
Bioventus Inc. (BVS) Stock Ownership
Institutional vs insider vs public ownership from 13F and float data — top holders, activity, and insider trades below.
SEC 13F · FMP · BVS · as of Mar 31, 2025
Ownership Breakdown
148
Institutional Holders
▼ 7 vs Q4
$448.28M
Total Inst. Value
▼ $29.56M vs Q4
67.75M
Shares Outstanding
freeFloat 69.38%
47.18M
13F Shares Held
▲ 1.66M vs Q4
Institutional ownership = 13F shares ÷ total outstanding. Insider % = 100 − free float. Public % = free float − institution %. Data: FMP /symbol-positions-summary + /shares-float + SEC EDGAR.
Top Institutional Holders
BVS largest shareholders · institutional ownership
Q1 2025 · SEC 13F
Showing top 10 holders
| Holder | Shares | % Owned | Weight | Value | Reported | Change |
|---|---|---|---|---|---|---|
ESSEX WOODLANDS MANAGEMENT, INC. surgical & medical instruments & apparatus | 13.02M | 19.73% | 19.73% | $119.15B | May 13, 2025 | — held |
JUNIPER INVESTMENT COMPANY, LLC surgical & medical instruments & apparatus | 6.94M | 10.51% | 10.51% | $63.50B | May 15, 2025 | — held |
NANTAHALA CAPITAL MANAGEMENT, LLC surgical & medical instruments & apparatus | 4.13M | 6.25% | 6.25% | $37.75B | May 15, 2025 | ▲ 98.8K |
BLACKROCK, INC. surgical & medical instruments & apparatus | 2.83M | 4.29% | 4.29% | $25.90B | May 2, 2025 | ▲ 37.6K |
VANGUARD GROUP INC surgical & medical instruments & apparatus | 2.55M | 3.87% | 3.87% | $23.37B | May 9, 2025 | ▲ 92.1K |
DIVISADERO STREET CAPITAL MANAGEMENT, LP surgical & medical instruments & apparatus | 1.69M | 2.56% | 2.56% | $15.48B | May 15, 2025 | NEW |
DRIEHAUS CAPITAL MANAGEMENT LLC surgical & medical instruments & apparatus | 1.45M | 2.19% | 2.19% | $13.22B | May 15, 2025 | ▲ 325.4K |
AMERICAN CENTURY COMPANIES INC surgical & medical instruments & apparatus | 1.04M | 1.58% | 1.58% | $9.55B | May 13, 2025 | ▲ 159.5K |
FMR LLC surgical & medical instruments & apparatus | 998.3K | 1.51% | 1.51% | $9.13B | May 12, 2025 | ▲ 29.4K |
GEODE CAPITAL MANAGEMENT, LLC surgical & medical instruments & apparatus | 932.8K | 1.41% | 1.41% | $8.54B | May 13, 2025 | ▼ 7.1K |
Data from SEC Form 13F filings. Ownership bar normalised to largest holder. Change flags: isNew / isSoldOut / changeInSharesNumber (FMP extract-analytics/holder).
Institutional Activity
Q1 2025 vs prior quarter
Q1 2025
27
Increased
+1.98M shares2
New Positions
first time holders16
Decreased
−646.9K shares0
Sold Out
fully exitedNet shares change (top 50)
+1.33M
+1.98M / −646.9K
Net new holders
+13
2 new / 0 exited
Based on top 50 institutional holders by position size. Fields: isNew, isSoldOut, changeInSharesNumber (FMP extract-analytics/holder, limit=50).
Insider Buying vs Selling
BVS insider trading · insider activity
Source: SEC Form 4
23
Buy transactions
16
Sell transactions
1.44
Buy/Sell ratio
$0M
Total disposed
Recent Insider Transactions
Showing 10 most recent · Common Stock only
| Name · Role | Date | Type | Shares | Price | Value | After Trans. | Filing |
|---|---|---|---|---|---|---|---|
Bartholdson John A.
| Jun 3, 2026 | Award | 25,146 | — | — | 25.1K | Form 4 ↗ |
SUTTER MARTIN P
| Jun 3, 2026 | Award | 25,146 | — | — | 25.1K | Form 4 ↗ |
STALNECKER SUSAN M director | Jun 3, 2026 | Award | 25,146 | — | — | 25.1K | Form 4 ↗ |
NOHRA GUY P director | Jun 3, 2026 | Award | 25,146 | — | — | 25.1K | Form 4 ↗ |
NEELS GUIDO J director | Jun 3, 2026 | Award | 25,146 | — | — | 25.1K | Form 4 ↗ |
McMurry-Heath Michelle director | Jun 3, 2026 | Award | 25,146 | — | — | 25.1K | Form 4 ↗ |
Ladone Mary Kay director | Jun 3, 2026 | Award | 25,146 | — | — | 25.1K | Form 4 ↗ |
Source: /insider-trading/search (FMP stable). Buy/Sell direction: acquisitionOrDisposition A=Buy, D=Sell. RSU vesting (M-Exempt) excluded from sentiment bar. All data from SEC EDGAR public filings.
About institutional & insider ownership
Bioventus Inc. (BVS) is primarily owned by institutional investors, who hold approximately 69.6% of total shares outstanding. Company insiders own approximately 30.62%, while retail and public investors account for the remaining 0.00%.
The largest institutional shareholder of Bioventus Inc. is ESSEX WOODLANDS MANAGEMENT, INC., holding approximately 13.02 million shares — equal to 19.73% of outstanding shares — as of March 31, 2025.
A total of 148 institutional investors currently hold BVS stock, with a combined institutional value of approximately $448,275,306 as of the most recent 13F filing period.
Frequently asked questions
BVS ownershipBioventus Inc. (BVS) is primarily owned by institutional investors, who hold approximately 69.6% of shares. The largest shareholder is ESSEX WOODLANDS MANAGEMENT, INC. with a 19.73% stake. Company insiders hold 30.62%. Data sourced from SEC Form 13F as of March 31, 2025.